Isobutyric acid (1R,8R,12R)-12-(2-{[3-(1H-benzoimidazol-2-yl)-propyl]-methyl-amino}-ethyl)-tricyclo[6.3.2.02,7]trideca-2,4,6-trien-12-yl ester

ID: ALA3609818

PubChem CID: 46203894

Max Phase: Preclinical

Molecular Formula: C30H39N3O2

Molecular Weight: 473.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C(=O)O[C@@]1(CCN(C)CCCc2nc3ccccc3[nH]2)C[C@H]2CCC[C@@H]1c1ccccc12

Standard InChI:  InChI=1S/C30H39N3O2/c1-21(2)29(34)35-30(20-22-10-8-13-25(30)24-12-5-4-11-23(22)24)17-19-33(3)18-9-16-28-31-26-14-6-7-15-27(26)32-28/h4-7,11-12,14-15,21-22,25H,8-10,13,16-20H2,1-3H3,(H,31,32)/t22-,25-,30+/m1/s1

Standard InChI Key:  BGWZTGQTWNIEFA-QPFIFXANSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -4.5500   -0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7900    0.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5600    1.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0800   -1.5300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8800   -0.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    0.9300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7400    1.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5200    3.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400    2.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600    1.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2800   -0.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3300    0.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0962   -0.8454    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6453    0.6045    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9422    3.7900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0815    2.8131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4975    3.3104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6369    2.3334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0529    2.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1922    1.8537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6082    2.3510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8012    1.5051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0211    3.7818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5142    3.8116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9988    2.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.4715    2.0924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.4652    3.2423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.9806    4.6566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.4906    4.9555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7189    4.4898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6132    4.2703    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3372    5.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4762    6.7229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2556    7.9024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6082    6.3245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7947    6.1439    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  0
 10 12  1  0
 12 13  1  0
 13 11  1  0
 10 14  1  6
  7 15  1  1
  8 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 26  1  0
 25 24  1  0
 24 22  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 18 31  1  0
  8 32  1  1
 32 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 33 37  2  0
M  END

Associated Targets(Human)

CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1H Tclin Voltage-gated T-type calcium channel alpha-1H subunit (1913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Heart (1007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 473.66Molecular Weight (Monoisotopic): 473.3042AlogP: 6.21#Rotatable Bonds: 9
Polar Surface Area: 58.22Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.54CX Basic pKa: 9.82CX LogP: 5.97CX LogD: 3.56
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -0.09

References

1. Renneberg D, Hubler F, Rey M, Hess P, Delahaye S, Gatfield J, Iglarz M, Hilpert K..  (2015)  Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.,  25  (18): [PMID:26231163] [10.1016/j.bmcl.2015.07.038]

Source